Find winning stocks in any market cycle. Join 7 million investors using Simply Wall St’s investing ideas for FREE.

• If you are wondering whether Corvus Pharmaceuticals’ recent share price puts it on your watchlist or your worry list, you are not alone.

• The stock last closed at US$18.66 after a 131.8% return over 30 days, a 154.9% return year to date, a 282.4% return over 1 year and a very large 3 year return, followed by a 7 day return of an 8.6% decline.

• Recent coverage has focused on Corvus Pharmaceuticals as a high risk, high potential biotech name, with attention on its pipeline and clinical progress as key drivers of sentiment. This context helps explain why the share price has moved so sharply over shorter and longer time…